I130T (p.Ile130Thr) variant of GCK (Hexokinase-4)

I130T (p.Ile130Thr) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.81 / 1. The record also includes population frequency data and structural context.

I130T (p.Ile130Thr) variant details